Our TeamExperienced business managers and experts in biotechnology R&D
About our team…
Several years ago, SafeWhite proved it was possible to whiten teeth using proteins naturally occurring in sea life. These proteins allow for teeth to function naturally while greatly improving teeth whiteness without the dryness and sensitivity caused by bleaching teeth. These discoveries are the basis for SafeWhite. After further refining the product, SafeWhite scientists are now able to whiten teeth in a manner that is both safe and effective.
Ray Shealy is a successful operator, investor and board member involved with a number of healthcare and technology-based companies. Ray served as President and CEO at HTP Inc., which was acquired by McKesson’s RelayHealth unit in 2008. Read more…
Gary Musso, PhD
Chief Science Officer
Dr. Musso has 25+ years of experience in both research and development has covered the transformation of science and technologies into clinically and commercially viable products.
Mark is a founder and investor in several other high-growth, technology-based companies, including Updox, InfoMotion Sports, and hc1.com. Mark was the founder of HUBLink, which became the global leader in hospital systems connectivity and is now the healthcare integration division of Infor.
Director of Marketing
Sam comes to SafeWhite with an extensive marketing and advertising experience. She’s worked with startups, prestigious universities, corporate entities, and large, distributed businesses. Building brands from scratch, creating effective ad campaigns, writing copy, and more—she’s had just about every role in an advertising agency.
At SafeWhite, she is hyperfocused on continually evolving the brand as well as pushing towards the top spot in the marketplace.
Scott is a molecular biologist specializing in molecular diagnostic testing, now acting as an executive within the In-Vitro Diagnostic Industry.
Vice President of Administration
Alan Fermier is an executive with experience in the medical products and service businesses. Alan led the SafeWhite team in the early stages of the product concept and development and continues to participate in several key aspects of the business including the development of SafeWhite’s growing intellectual property portfolio and relationships with clinical partners.
Satish Garre, PhD
Satish has over 11 years of research experience in the design and synthesis of novel small molecules for application in asymmetric synthesis, drug discovery and biochemistry. He received his PhD in Organic Chemistry from Wayne State University and his Master of Science in Chemistry from Texas A&M University.
Senior Research Associate
Caitlin is a research associate on the science team at SafeWhite. Before SafeWhite, she was involved in dental research on cavity fillings at The Ohio State University.